GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS
Completed · Phase 3 · Has a placebo group
Conditions studied: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome
In brief
The GRACE-2 study is a prospective, multi-center, double-blind, randomized controlled trial of the drug GM-CSF vs placebo in children with sepsis-induced multiple organ dysfunction syndrome (MODS) who have immunoparalysis with mild to moderate inflammation.
Key facts
- Study ID
- NCT05266001
- Run by
- Nationwide Children's Hospital
- People needed
- 141
- Starts
- 2022-06-14
- Expected to finish
- 2025-09-10
- Last updated by the study team
- 2026-04-09
Who can join
Age: 0 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥ 40 weeks corrected gestational age to < 18 years; AND
- Admission to the PICU or CICU; AND
- Onset of ≥ 2 new organ dysfunctions within the last 3 calendar days (compared to pre-sepsis baseline) as measured by the modified Proulx criteria; AND
- Documented or suspected infection as the MODS inciting event.
You may not qualify if…
- Weight <3kg; OR
- Limitation of care order at the time of screening; OR
- Patients at high likelihood of progression to brain death in opinion of the clinical team; OR
- Moribund condition in which the patient is unlikely to survive the next 48 hours in opinion of the clinical team; OR
- History of myeloid leukemia, myelodysplasia, or autoimmune thrombocytopenia; OR
- Current or prior diagnosis of hemophagocytic lymphohistiocytosis or macrophage activation syndrome; OR
- Peripheral white blood cell count < 1,000 cells/mm3 as the result of myeloablative therapy OR receipt of myeloablative therapy within the previous 14 days; OR
- Known allergy to GM-CSF; OR
- Known pregnancy; OR
- Lactating females; OR
- Receipt of anakinra or GM-CSF within the previous 28 days; OR
- Resolution of MODS by MODS Day 2; OR
- Previous enrollment in the GRACE-2 study.
Where it is running
- Arkansas Children's Hospital — Little Rock, Arkansas, United States
- Children's Hospital of Los Angeles — Los Angeles, California, United States
- Benioff Children's Hospital - Oakland — Oakland, California, United States
- Children's Hospital of Orange County — Orange, California, United States
- University of California - Davis — Sacramento, California, United States
- Benioff Children's Hospital - Mission Bay — San Francisco, California, United States
- Children's Hospital Colorado — Aurora, Colorado, United States
- Children's National Medical Center — Washington D.C., District of Columbia, United States
- CS Mott Children's Hospital — Ann Arbor, Michigan, United States
- Children's Hospital of Michigan — Detroit, Michigan, United States
- Children's Hospital of Minnesota — Minneapolis, Minnesota, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Mercy Children's Hospital — Kansas City, Missouri, United States
- Duke University — Durham, North Carolina, United States
- Rainbow Babies and Children's Hospital — Cleveland, Ohio, United States
- Nationwide Children's Hospital — Columbus, Ohio, United States
- Pennsylvania State University — Hershey, Pennsylvania, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
- Texas Children's Hospital — Houston, Texas, United States
- Children's Hospital of San Antonio — San Antonio, Texas, United States
- Primary Children's Hospital — Salt Lake City, Utah, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.